Keywords
Last Name

Shakun Karki, PhD

TitleInstructor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionCardiovascular Medicine
Address72 E. Concord St Evans Building
Boston MA 02118
Phone(617) 638-5075
 Awards and Honors

Start-EndDescription
2011-2012Training Cardiovascular Biology: Predoctoral: 5T32HL007969-02
2013Postdoctoral: Whitaker Cardiovascular Institute, Boston University: T32 HL07224
2001-2001University of New Hampshire: Summer Teaching Fellow
2014Boston University Medical School: Evans Day-Best Clinical Research, Runner up
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Farb MG, Karki S, Park SY, Saggese SM, Carmine B, Hess DT, Apovian C, Fetterman JL, Bretón-Romero R, Hamburg NM, Fuster JJ, Zuriaga MA, Walsh K, Gokce N. WNT5A-JNK regulation of vascular insulin resistance in human obesity. Vasc Med. 2016 Dec; 21(6):489-496. PMID: 27688298.
    View in: PubMed
  2. Karki S, Farb MG, Myers S, Apovian C, Hess DT, Gokce N. Effect of Bariatric Weight Loss on the Adipose Lipolytic Transcriptome in Obese Humans. Mediators Inflamm. 2015; 2015:106237. PMID: 26663986.
    View in: PubMed
  3. Karki S, Farb MG, Ngo DT, Myers S, Puri V, Hamburg NM, Carmine B, Hess DT, Gokce N. Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity. Arterioscler Thromb Vasc Biol. 2015 Jun; 35(6):1498-506. PMID: 25908760.
    View in: PubMed
  4. Ngo DT, Farb MG, Kikuchi R, Karki S, Tiwari S, Bigornia SJ, Bates DO, LaValley MP, Hamburg NM, Vita JA, Hess DT, Walsh K, Gokce N. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation. 2014 Sep 23; 130(13):1072-80. PMID: 25116954.
    View in: PubMed
  5. Karki S, Ngo DT, Bigornia S, Farb MG, Gokce N. . Exp Rev Endo & Metab. Insulin resistance: A key therapeutic target for cardiovascular risk reduction in obese patients. 2014.
  6. Bigornia SJ, Farb MG, Tiwari S, Karki S, Hamburg NM, Vita JA, Hess DT, Lavalley MP, Apovian CM, Gokce N. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol. 2013 Dec 17; 62(24):2297-305. PMID: 23978693.
    View in: PubMed
  7. Farb MG, Tiwari S, Karki S, Ngo DT, Carmine B, Hess DT, Zuriaga MA, Walsh K, Fetterman JL, Hamburg NM, Vita JA, Apovian CM, Gokce N. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity (Silver Spring). 2014 Feb; 22(2):349-55. PMID: 23640904.
    View in: PubMed
  8. Farb, MG, Tiwari, S, Karki S, Ngo,DTM Carmine,B, Hess, DT, Zuriaga,M Walsh, K, Fetterman, JL, Hamburg, NM, Vita, JA, Apovian, C and Gokce, N. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity. 2013.
  9. Karki S, Chakrabarti P, Huang G, Wang H, Farmer SR, Kandror KV. The multi-level action of fatty acids on adiponectin production by fat cells. PLoS One. 2011; 6(11):e28146. PMID: 22140527.
    View in: PubMed
  10. Chakrabarti P, English T, Karki S, Qiang L, Tao R, Kim J, Luo Z, Farmer SR, Kandror KV. SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res. 2011 Sep; 52(9):1693-701. PMID: 21743036.
    View in: PubMed
  11. Bobilya DJ, Gauthier NA, Karki S, Olley BJ, Thomas WK. Longitudinal changes in zinc transport kinetics, metallothionein and zinc transporter expression in a blood-brain barrier model in response to a moderately excessive zinc environment. J Nutr Biochem. 2008 Feb; 19(2):129-37. PMID: 18061429.
    View in: PubMed
Shakuntala's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department